BCM
IRWD icon

Burrage Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Burrage Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-115,899
Closed -$1.17M – 28
2020
Q1 		$1.17M Buy
+115,899
New +$1.36M 1.15% 26

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Burrage Capital Management's IRWD Position: Q2 2020 in Review

Burrage Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2020, closing a stake of 115,899 shares — an estimated $1.17M sold.

Burrage Capital Management first reported a position in IRWD in Q1 2020 and held it in 1 quarter. The position peaked at $1.17M in Q1 2020. 202 funds tracked by Wall St. Rank hold IRWD as of Q2 2020.

  • Burrage Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Burrage Capital Management sold 115,899 Ironwood Pharmaceuticals shares in Q2 2020, an estimated $1.17M.
  • Burrage Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Burrage Capital Management's Ironwood Pharmaceuticals position peaked at $1.17M in Q1 2020.
  • 202 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2020.

Based on Burrage Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.